Analytics
Consensus Analysis | Astra Zeneca | 6 August 2026
Novo misses, AstraZeneca holds steady, Alvotech clears FDA – the Nordic Pulse | 2026:31
Novo sues Lilly, Alligator collapses, Lundbeck completes Phase III – the Nordic Pulse | 2026:30
Leqembi under the skin, Wegovy wins Europe, Sobi lifts guidance – the Nordic Pulse | 2026:29
AstraZeneca drags the index, Ascelia contests the FDA and board drama at BICO – the Nordic Pulse | 2026:28
BioVal™ analysis: Alzinova’ ALZ-101 valued at SEK 7.1B
BioVal
Hansa closes, AlzeCure soars, Ascelia falters – the Nordic Pulse | 2026:27
Analytics
State of Nordic Biopharma | Q2 2026
Analytics
BioVal™ analysis: Elicera Therapeutics’ ELC-301 valued at SEK 631M
BioVal
BioArctic lands Lilly, Sobi takes a late hit – the Nordic Pulse | 2026:26
Alvotech cashes up, SynAct narrowly misses – the Nordic Pulse | 2026:25
